期刊文献+

多沙唑嗪对PTCA术后再狭窄的防治作用机制 被引量:1

Research on the mechanism of Doxazosin for preventing and treating restenosis after PTCA operation
下载PDF
导出
出处 《实用医药杂志》 2002年第9期711-712,共2页 Practical Journal of Medicine & Pharmacy
  • 相关文献

参考文献16

  • 1Serruys PW,de Jaegere P,Kiemeneij F,et al.A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary disease. N Engl J Med, 1994,331(8):489
  • 2彭久合,魏玉金,夏霖,倪沛洲.α_1-肾上腺素受体拮抗剂的研究[J].药学进展,1995,19(4):206-211. 被引量:10
  • 3郑晓云,李文明,陈国祥,杨解人.国产甲磺酸多沙唑嗪长期毒性实验[J].蚌埠医学院学报,1998,23(3):150-151. 被引量:2
  • 4毛焕元.(5)α1受体阻滞剂治疗高血压的现状[J].中国循环杂志,1997,12(3):163-163. 被引量:9
  • 5Vashisht R,Sian M,Franks PJ, et al.Long-term reduction of intimal hyperplasia by the selective alpha-1 adrenergic antagonist doxazosin. Br J Surg, 1992,79:1285
  • 6Polyak K, Lee MH,Erdjument Bromage H, et at. Cloning of p27kipl, a cvclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 1994,78(1):59
  • 7Braun Dullaeus RC, Mann M J, Dzau V J, et al. Cell cycleprogression:new therapeutic target for vascular proliferative disease. Circulation, 1998,98( 1 ):82
  • 8Zhuo-Wei Hu, Xiao-You Shi, Brian B.Hoffman, et al.Doxazosin inhibits proliferation and migration of human vascularsmooth -muscle cells independent of α1 -adrergic receptorantagonism. Journal of Cardiovascular Pharmacology, 1998,31:833
  • 9Kintscher U, Wakino S, Kims S, et al. Doxazosin inhibits retinoblastoma protein phosphorylation and G1-S transition in human coronary smooth muscle cells. Arterioscler Thromb Vasc Biol,2000,20:1216
  • 10Janero DR,Ewing JF.Nitric oxide and postangioplasty restenosis:pathological correlates and therapeutic potential. Free RadicBiol Med,2000,29(12):1199

二级参考文献1

  • 1Young RA,Brogden RN.Doxazosin-A review of its pharmacodynamic and pharmacokinetic properties,and therapeutic efficacy in mild or moderate hypertension.Drugs,1989,35(5):525.

共引文献18

同被引文献10

  • 1[1]Popma JJ,Calif RM,Topol EL.Clinical trials of restenosis after coronary angioplasty. Circulation, 1991,84:1426 -1436.
  • 2[2]Schiele TM, Krotz F, Klauss V.Vascular restenosis striving for therapy. Expert Opin Pharmacother, 2004,5: 2221-2232.
  • 3[3]Roehrborn CG,Schwinn DA.Alphal adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. J Urol, 2004,171:1029-1035.
  • 4[6]Vashisht R,Sian M,Franks PJ,et al. Long-term reduction of intimal hyperplasia by the selective alpha-1 adrenergic antagonist doxazosin. Br J Surg, 1992,79 :1285-1288.
  • 5[7]Kintscher U,Wakino S,Kim S,et al. Doxazosin inhibits retinoblastoma protein phosphorylation and G (1)->S transition in human coronary smooth muscle cells. Arterioscler Thromb Vasc Biol,2000,20:1216-1224.
  • 6[8]Tojo A,Kobayashi N,Kimura K,et al. Effects of antihypertensive drugs on nitric oxide synthase activity in rat kidney. Kidney Int Suppl, 1996,55 :S138-S140.
  • 7[10]Lee J S,Adrie C,Jaeob HJ,et al. Chronic inhalation of nitric oxide inhibits neointimal formation after ballooninduced arterial injury. Circ Res,1996,78:337-342.
  • 8[11]Sato J,Nair K,Hiddinga J,et al.eNOS genetransfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis.Cardiovasc Res, 2000,47:697-706.
  • 9侯英萍,乔宏庆.血管再狭窄的动物模型与放射性治疗[J].心脏杂志,2000,12(1):43-44. 被引量:6
  • 10杨君,秦永文.多沙唑嗪对高血压患者动脉血管平滑肌细胞NO产生的影响[J].山东医药,2001,41(22):15-16. 被引量:2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部